Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Lecanemab, as the drug is known, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the underlying condition and not its symptoms. The treatment could ...

From the Treasure Coast, now to Palm Beach County, a new era of hope for families battling Alzheimer’s and cognitive decline ...

The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...

Have you ever forgotten something so simple and mundane like what you ate the other day repeatedly? If the answer is yes, then you might want to get a Neurologist consultation for Alzheimer's disease.

Management cited the divestiture and consolidation of non-core early development sites, resulting in a reduction of approximately $50 million in annual revenue. The company lowered its midpoint ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Area residents are invited to lace up their shoes for the 2025 Walk to End Alzheimer’s — Wilmington on Saturday, Nov. 1. READ ...

Early detection of Alzheimer’s disease has come a step closer thanks to a new measurement method developed by chemists at Utrecht University. Notorious protein clumps involved in dementias such ...

If you've experienced a loved one dealing with dementia, As Long As You're Here is a moving, powerful journey worth taking. Here's our full review.

Neuropsychiatric disorder specialist MapLight Therapeutics has made its debut on the Nasdaq, raising $251 million and ...

The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...